|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7-9
|
|
pubmed:dateCreated |
1981-12-15
|
|
pubmed:abstractText |
vitamin compounds to the basic dialytic treatment of renal osteodystrophy is of contestable interest. Because 1) optimum conditions of dialysis without D vitamin addition prevent efficiently the progress of severe gyperparathyroidism and osteomalacia 2) the D vitamin compunds could render the phosphatemia control more difficult thus contributing to aggravate the histologic lesions of hyperparathyroidism.
|
|
pubmed:language |
fre
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0035-2659
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
48
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
535-41
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:7291931-Adult,
pubmed-meshheading:7291931-Bone and Bones,
pubmed-meshheading:7291931-Calcifediol,
pubmed-meshheading:7291931-Drug Therapy, Combination,
pubmed-meshheading:7291931-Female,
pubmed-meshheading:7291931-Humans,
pubmed-meshheading:7291931-Hydroxycholecalciferols,
pubmed-meshheading:7291931-Kidney Failure, Chronic,
pubmed-meshheading:7291931-Male,
pubmed-meshheading:7291931-Middle Aged,
pubmed-meshheading:7291931-Parathyroid Hormone,
pubmed-meshheading:7291931-Phosphates,
pubmed-meshheading:7291931-Renal Dialysis,
pubmed-meshheading:7291931-Renal Osteodystrophy
|
|
pubmed:articleTitle |
[Long-term effects of a combination of 25-hydroxycholecalciferol and 1-alpha-hydroxycholecalciferol on osteodystrophy in chronic hemodialysis patients].
|
|
pubmed:publicationType |
Journal Article,
English Abstract,
Research Support, Non-U.S. Gov't
|
